salubrinal and pterostilbene

salubrinal has been researched along with pterostilbene* in 1 studies

Other Studies

1 other study(ies) available for salubrinal and pterostilbene

ArticleYear
Inhibition of eIF2α dephosphorylation accelerates pterostilbene-induced cell death in human hepatocellular carcinoma cells in an ER stress and autophagy-dependent manner.
    Cell death & disease, 2019, 05-28, Volume: 10, Issue:6

    Hepatocellular carcinoma (HCC) is the one of the most common cancers worldwide. Because the side effects of current treatments are severe, new effective therapeutic strategies are urgently required. Pterostilbene (PT), a natural analogue of resveratrol, has diverse pharmacologic activities, including antioxidative, anti-inflammatory and antiproliferative activities. Here we demonstrated that PT inhibits HCC cell growth without the induction of apoptosis in an endoplasmic reticulum (ER) stress- and autophagy-dependent manner. Mechanistic studies indicated that the combination of salubrinal and PT modulates ER stress-related autophagy through the phospho-eukaryotic initiation factor 2α/activating transcription factor-4/LC3 pathway, leading to a further inhibition of eIF2α dephosphorylation and the potentiation of cell death. An in vivo xenograft analysis revealed that PT significantly reduced tumour growth in mice with a SK-Hep-1 tumour xenograft. Taken together, our results yield novel insights into the pivotal roles of PT in ER stress- and autophagy-dependent cell death in HCC cells.

    Topics: Activating Transcription Factor 4; Animals; Antineoplastic Agents; Apoptosis; Autophagosomes; Autophagy; Carcinoma, Hepatocellular; Cinnamates; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Signal Transduction; Stilbenes; Thiourea; Transplantation, Heterologous

2019